Evolus Inc

Research Evolus Inc (EOLS) on Bullrun: market cap USD 469.54M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEOLS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 469.54M
• Financial periodFY2025
• RevenueUSD 297.18M
• Revenue growth11.6%
• Net income-USD 51.64M
• Free cash flow-USD 45.71M
• Gross margin66.3%

Valuation Snapshot

latest market cap is USD 469.54M.

About Evolus Inc

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes.

Frequently asked questions

What is Evolus Inc's market cap?

Evolus Inc's market capitalization is USD 469.54M.

What does Evolus Inc do?

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.